Adherence to treatment in systemic lupus erythematosus patients - Archive ouverte HAL Access content directly
Journal Articles Best Practice and Research: Clinical Rheumatology Year : 2013

Adherence to treatment in systemic lupus erythematosus patients

(1, 2) , (3, 1) , (4, 5) , (2) , (6) , (7) , (2) , (6)
1
2
3
4
5
6
7

Abstract

Adherence is defined as "the extent to which a person's behaviour coincides with medical or health advice." Poor adherence to therapeutic regimens is a common and expensive problem in patients with chronic diseases including systemic lupus erythematosus (SLE) and is associated with a higher risk of flares, morbidity, hospitalisations and poor renal outcome. Non-adherence to the treatment is multifactorial for most patients and varies according to unintentional or intentional patterns. The rates of non-adherence in SLE patients range from 3% to 76% depending on the assessment methods, which are all subject to limitations. Indeed, poor adherence to therapeutic regimens is difficult to evaluate. Two studies have shown that undetectable blood hydroxychloroquine (HCQ) concentration may be a simple, objective and reliable marker of non-adherence in SLE patients. The accurate diagnosis of non-adherence may prevent one from incorrectly interpreting disease manifestations as a lack of response. It may then avoid an unnecessary or even dangerous treatment escalation.
Not file

Dates and versions

hal-01791229 , version 1 (14-05-2018)

Identifiers

Cite

Nathalie Costedoat-Chalumeau, Jacques Pouchot, Gaëlle Guettrot-Imbert, Veronique Le Guern, Gaëlle Leroux, et al.. Adherence to treatment in systemic lupus erythematosus patients. Best Practice and Research: Clinical Rheumatology, 2013, 27 (3), pp.329 - 340. ⟨10.1016/j.berh.2013.07.001⟩. ⟨hal-01791229⟩
22 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More